Olema Pharmaceuticals (OLMA) Shares Outstanding (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Shares Outstanding data on file, last reported at $87.3 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $87.3 million, up 27.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $87.3 million (up 27.8% YoY), and the FY2025 annual result was $81.4 million, up 9.51% from the prior year.
• Shares Outstanding climbed to $87.3 million in Q1 2026 per OLMA's latest filing, from $81.4 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $87.3 million in Q1 2026 and troughed at $39.9 million in Q1 2022.
• A 5-year average of $57.1 million and a median of $55.9 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding increased 1.02% in 2022, then surged 39.21% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $40.3 million in 2022, then jumped by 36.5% to $55.0 million in 2023, then jumped by 35.13% to $74.3 million in 2024, then gained by 9.51% to $81.4 million in 2025, then grew by 7.32% to $87.3 million in 2026.
• Business Quant data shows OLMA's Shares Outstanding at $87.3 million in Q1 2026, $81.4 million in Q4 2025, and $68.7 million in Q3 2025.